What's new

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised

Mar 14, 2025 - 16:11
 0
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Revinty Ellipta, fluticasone furoate,vilanterol, Date of authorisation: 02/05/2014, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Brad Pitt's 'F1' Has A Nonsensical Plot, But I Can't Look Away From The Trailer

Next Article

MISO overstates transmission plan benefits by excluding Invenergy project: marke...

Related Posts

PSUSA/00000342/202407

PSUSA/00000342/202407

Feb 13, 2025  0

Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 February 2025, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025 to 13 February 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 10 ...

Feb 10, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi, Risankizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0492/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0